A Safety and Efficacy Study of ELND002 in Patients With Relapsing Forms of Multiple Sclerosis
Clinical trial NCT01144351 · TERMINATED
Trial details
- NCT number
- NCT01144351
- Sponsor
- Elan Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-03-01
- Primary completion
- 2012-12-01
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.